Global Capnography Equipment Market, By Products (Mainstream Capnographs, Sidestream Capnographs, and Microstream Capnographs), By Application (Cardiac care, Trauma, Emergency care, Respiratory disorder, and Others), By End User (Hospitals, Ambulatory surgical center, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa). Global capnography equipment market was valued at US$ 360.8 Mn in 2024 and is expected to reach US$ 506.0 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.9% from 2024 to 3031, as highlighted in a new report published by Coherent Market Insights.
Increasing research and development activities by key players in the market are expected to drive the growth of the segment over the forecast period. For instance, in September 2021, RenJi Hospital, a hospital based in China, initiated a clinical trial titled, “Capnographic Monitoring Decrease the Incidence of Hypoxia of the Elderly Patients Undergoing Gastrointestinal Endoscopy Procedure: a Randomized Multicenter Clinical Trial.” The aim of this randomized study was to determine whether intervention based on additional capnographic monitoring reduces the incidence of hypoxia in gastrointestinal endoscope procedures for elderly patients.
Global Capnography Equipment Market - Impact of Coronavirus (COVID-19) Pandemic
The emergence of the COVID-19 pandemic is expected to offer lucrative growth opportunities for players in the global capnography equipment market. For instance, on September 23, 2020, there were 31,425,029 confirmed cases of COVID-19 including 967,164 deaths as reported by the World Health Organization (WHO).
Global Capnography Equipment Market: Key Developments
In September 2020, Capsule Technologies, a global provider of medical devices, announced that the company has received U.S. Food and Drug Administration (FDA) approval for its capnography monitor. The new tool can monitor a patient's end-tidal carbon dioxide, respiratory rate, and fractional inspired CO2.
In November 2021, Smile Train, a provider of corrective surgery for children with cleft palate, and Lifebox, a global non-profit organization that saves lives through safer surgery and anesthesia, launched “The Smile Train-Lifebox Capnography Project.” The Smile Train-Lifebox Capnography Project seeks to find a “capnography solution” to provide comprehensive, safe cleft care through improved patient monitoring during surgery in resource-limited settings. Due to its technical requirements, as well as the cost, capnography is not available in many operating rooms globally. Smile Train and Lifebox have developed specifications for a capnography device specifically designed for the intraoperative care of children including those having cleft surgery, in low-resource settings.
In June 2019, Masimo Corporation, a medical device company, received the U.S. FDA approval for its O3 Regional Oximetry for use on neonatal and infant patients.
Browse 35 Market Data Tables and 33 Figures spread through 160 Pages and in-depth TOC on “Global Capnography Equipment Market” - Forecast to 2030, Global Capnography Equipment Market, By Products (Mainstream Capnographs, Sidestream Capnographs, and Microstream Capnographs), by Application (Cardiac care, Trauma, Emergency care, Respiratory disorder, and Others), by End User (Hospitals, Ambulatory surgical center, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Link: https://www.coherentmarketinsights.com/market-insight/capnography-devices-market-433
Key Takeaways of the Global Capnography Equipment Market:
- The global capnography equipment market is expected to exhibit a CAGR of 4.9% during the forecast period. Merger with emerging economies offers lucrative growth opportunities for players in the global capnography equipment market
- Among application, the respiratory disorder segment is expected to hold a dominant position in the global capnography equipment market during the forecast period, and this is attributed to the increasing prevalence of respiratory disorders such as asthama and chronic obstructive pulmonary disease (COPD). For instance, according to data published on May 1, 2023 by the National Library of Medicine, in the U.S. more than 25 million people have asthma, and approximately 14.8 million adults have been diagnosed with chronic obstructive pulmonary disease (COPD) in 2022.
- Among region, North America is expected to be the dominant region in the global capnography equipment market owing to increasing research and development activities by the key players in the region. For instance, in September 2021, Masimo, a global medical device company, announced results from its clinical trial studies, that its EMMA capnography is effective for infants on ventilators. EMMA offers capnography with accurate EtCO2 and respiration rate readings along with continuous EtCO2 waveforms displayed within 15 seconds.
- The major players operating in the global capnography equipment market are Drägerwerk AG & Co. KGaA, Masimo Corporation, Medtronic, Inc., Nihon Kohden Corporation, Nonin Medical, Inc., Philips Healthcare, Smiths Medical, and Welch Allyn, Inc.
